Alison Boyle
Impact in
- Infectious Diseases top 10%
- COVID-19 Clinical Research Studies
- SARS-CoV-2 and COVID-19 Research
- HIV/AIDS drug development and treatment
-
- Pharmacogenetics and Drug Metabolism
- Antibiotics Pharmacokinetics and Efficacy
Papers in
-
- Hepatitis C virus research 4
-
- HIV/AIDS drug development and treatment 2
- Co-authors
- Catia Marzolini (4 shared papers)Saye Khoo (4 shared papers)Fiona Marra (9 shared papers)Sara Gibbons (3 shared papers)David Back (3 shared papers)David M. Burger (2 shared papers)Marta Boffito (1 shared paper)Charles Flexner (1 shared paper)
- Journals
- Journal of Hepatology (3 papers)Journal of Viral Hepatitis (2 papers)Clinical Pharmacology & Therapeutics (1 paper)Clinical Pharmacokinetics (1 paper)Journal of Critical Care (1 paper)
- Partner nations
- United KingdomSwitzerlandNetherlands
In The Last Decade
Alison Boyle
8 papers receiving 260 citations
Alison Boyle's Hit Papers
Peers
Comparison fields: 5 of 70
- Infectious Diseases 168
- Pharmacology 35
- Transplantation 8
- Toxicology 10
- Geriatrics and Gerontology 10
Countries citing papers authored by Alison Boyle
This map shows the geographic impact of Alison Boyle's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alison Boyle with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alison Boyle more than expected).
Fields of papers citing papers by Alison Boyle
This network shows the impact of papers produced by Alison Boyle. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alison Boyle. The network helps show where Alison Boyle may publish in the future.
Co-authors
The 25 scholars most cited alongside Alison Boyle, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Recommendations for the Management of Drug–Drug Interactions Between the Hit paper breakdown → | 2022 | 162 |
| 2 | 2020 | 39 | |
| 3 | 2019 | 26 | |
| 4 | 2020 | 25 | |
| 5 | 2019 | 4 | |
| 6 | 2019 | 3 | |
| 7 | 2022 | 3 | |
| 8 | 2011 | 2 | |
| 9 | 2023 | 0 | |
| 10 | 2020 | 0 | |
| 11 | 2019 | 0 |
About Alison Boyle
Alison Boyle is a scholar working on Hepatology, Infectious Diseases, Epidemiology, Pharmacology and Surgery, having authored 11 papers that have together received 264 indexed citations. Recurring topics across this work include Hepatitis C virus research (4 papers), Drug-Induced Hepatotoxicity and Protection (3 papers), Pharmacogenetics and Drug Metabolism (2 papers), HIV/AIDS drug development and treatment (2 papers), Heparin-Induced Thrombocytopenia and Thrombosis (2 papers), Oral and gingival health research (1 paper), HIV Research and Treatment (1 paper) and Analytical Methods in Pharmaceuticals (1 paper). The work is most often cited by research in Infectious Diseases (168 citations), Pharmacology (35 citations), Transplantation (8 citations), Toxicology (10 citations) and Geriatrics and Gerontology (10 citations). Alison Boyle has collaborated with scholars based in United Kingdom, Switzerland and Netherlands. Frequent co-authors include Catia Marzolini, Saye Khoo, Fiona Marra, Sara Gibbons, David Back, David M. Burger, Marta Boffito, Charles Flexner, Laura Waters and Anton Pozniak. Their work appears in journals such as Journal of Hepatology, Journal of Viral Hepatitis, Clinical Pharmacology & Therapeutics, Clinical Pharmacokinetics and Journal of Critical Care.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.